Secukinumab Secukinumab is a mAb against IL-17A, known as SECU or AIN457 also

Secukinumab Secukinumab is a mAb against IL-17A, known as SECU or AIN457 also. take part in the pathogenesis of MS, such as dendritic cells (DCs), organic killer cells, B cells, and macrophages. DCs are professional antigen delivering cells (APCs) that are of great importance in mediating immune system responses by giving signaling transduction HUP2 for… Continue reading Secukinumab Secukinumab is a mAb against IL-17A, known as SECU or AIN457 also